SUBSCRIBE
SUBSCRIBE

Fibrobiologics

IN THE PRESS
Press Releases
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions
December 11, 2025
 · 
4 min read
Press Releases
FibroBiologics Announces Payoff of Outstanding Debt
November 27, 2025
 · 
4 min read
Press Releases
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 26, 2025
 · 
5 min read
Press Releases
FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 24, 2025
 · 
5 min read
Press Releases
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
November 21, 2025
 · 
5 min read
Press Releases
FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2025
 · 
6 min read
Press Releases
FibroBiologics Announces Pricing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2025
 · 
6 min read
Press Releases
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 2, 2025
 · 
7 min read
Press Releases
FibroBiologics to Present at Bio-Europe 2025
October 27, 2025
 · 
1 min read
Press Releases
FibroBiologics to Present at the 2025 ThinkEquity Conference
October 15, 2025
 · 
1 min read
Load More
JOBS